Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission

IntroductionIn vivo bioluminescence imaging (BLI) is a promising technique for non-invasive tumour imaging. d-luciferin can be administrated intraperitonealy or intravenously. This will influence its availability and, therefore, the bioluminescent signal. The aim of this study is to compare the repeatability of BLI measurement after IV versus IP administration of d-luciferin and assess the correlation between photon emission and histological cell count both in vitro and in vivo.Materials and methodsFluc-positive R1M cells were subcutaneously inoculated in nu/nu mice. Dynamic BLI was performed after IV or IP administration of d-luciferin. Maximal photon emission (PEmax) was calculated. For repeatability assessment, every acquisition was repeated after 4 h and analysed using Bland-Altman method. A second group of animals was serially imaged, alternating IV and IP administration up to 21 days. When mice were killed, PEmax after IV administration was correlated with histological cell number.ResultsThe coefficients of repeatability were 80.2% (IV) versus 95.0% (IP). Time-to-peak is shorter, and its variance lower for IV (p < 0.0001). PEmax was 5.6 times higher for IV. A trend was observed towards lower photon emission per cell in larger tumours.ConclusionIV administration offers better repeatability and better sensitivity when compared to IP. In larger tumours, multiple factors may contribute to underestimation of tumour burden. It might, therefore, be beneficial to test novel therapeutics on small tumours to enable an accurate evaluation of tumour burden.

[1]  P. Bruggen,et al.  Transduced with Lentiviruses Several MAGE Genes Using Dendritic Cells Presented by HLA-Cw 7 and Encoded by Identification of New Antigenic Peptide , 2004 .

[2]  Shingo Baba,et al.  How Reproducible Is Bioluminescent Imaging of Tumor Cell Growth? Single Time Point versus the Dynamic Measurement Approach , 2007, Molecular imaging.

[3]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  D. Jenkins,et al.  Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis , 2004, Clinical & Experimental Metastasis.

[5]  Craig S. Levin,et al.  Primer on molecular imaging technology , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  C. Contag,et al.  Use of reporter genes for optical measurements of neoplastic disease in vivo. , 2000, Neoplasia.

[7]  Wafik S El-Deiry,et al.  Bioluminescent Molecular Imaging of Endogenous and Exogenous p53-Mediated Transcription In Vitro and In Vivo Using an HCT116 Human Colon Carcinoma Xenograft Model , 2003, Cancer biology & therapy.

[8]  C. Contag,et al.  Noninvasive assessment of tumor cell proliferation in animal models. , 1999, Neoplasia.

[9]  M. Dewhirst,et al.  Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. , 2004, The Journal of surgical research.

[10]  E. van Marck,et al.  Temporal distribution of distinct mast cell phenotypes during intestinal schistosomiasis in mice , 2002, Parasite immunology.

[11]  J. Min,et al.  Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor Model , 2007, Clinical Cancer Research.

[12]  C. Niemann,et al.  Isoflurane Alters the Recirculatory Pharmacokinetics of Physiologic Markers , 2000, Anesthesiology.

[13]  Peter P. Antich,et al.  Validating Bioluminescence Imaging as a High-Throughput, Quantitative Modality for Assessing Tumor Burden , 2004 .

[14]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[15]  Masafumi Oshiro,et al.  Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter , 1997, Photochemistry and photobiology.

[16]  W. D. Mcelroy,et al.  Introduction to beetle luciferases and their applications. , 1989, Journal of bioluminescence and chemiluminescence.

[17]  K. Nagai,et al.  Quantitative and Continuous Analysis of ATP Release from Blood Platelets with Firefly Luciferase Luminescence , 1985, Thrombosis and Haemostasis.

[18]  C. Scatena,et al.  Imaging of bioluminescent LNCaP‐luc‐M6 Tumors: A new animal model for the study of metastatic human prostate cancer , 2004, The Prostate.

[19]  J. W. Hastings,et al.  Chemistries and colors of bioluminescent reactions: a review. , 1996, Gene.

[20]  C. Contag,et al.  Advancing animal models of neoplasia through in vivo bioluminescence imaging. , 2002, European journal of cancer.

[21]  R A Moats,et al.  Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. , 2003, BioTechniques.

[22]  Daniel E. Hall,et al.  Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. , 2000, Neoplasia.

[23]  N. Ugarova,et al.  Bioluminescent assay of total bacterial contamination of drinking water. , 2007, Luminescence : the journal of biological and chemical luminescence.

[24]  M. Dullaers,et al.  Lentivirally transduced dendritic cells as a tool for cancer immunotherapy , 2003, The journal of gene medicine.